| Expression pattern: |
UP |
| Associated gene: |
CTNND1 |
| Associated microRNA: |
miR-1299 |
| Biological function: |
Promotes HCC cell proliferation, cell cycle progression, migration and invasion, and promotes tumor growth in vivo. |
| Molecular mechanism: |
Acts as a miRNA sponge (ceRNA) for miR-1299, thereby protecting/stabilizing CTNND1 expression and promoting tumorigenic features. |
| Biological pathway or process: |
proliferation (promotes); cell cycle (promotes); migration (promotes); invasion (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
H
M
|
| Validation methods: |
Microarray; RT-qPCR; FISH / smFISH; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RNase R Treatment; Luciferase Reporter Assay; Bioinformatics Analysis; Transfection; CCK8; Colony Formation Assay; Cell Cycle Assay; Transwell Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry) |
| Clinical significance: |
circMAST1 may serve as a novel biomarker for HCC. |
| Description: |
circMAST1 is up-regulated in hepatocellular carcinoma and acts as an oncogenic circRNA. It promotes proliferation, cell-cycle progression, migration/invasion, and tumor growth by sponging miR-1299 and relieving miR-1299-mediated suppression of CTNND1 (circMAST1/miR-1299/CTNND1 axis). |
| Confidence score: |
0.807 |